Pain Point, Solved 4.9 ★★★★★ Google Rating

Why Does One Sleep Apnea Workup Need Two or Three Separate Authorizations?

One sleep apnea workup needs two or three separate authorizations because payer policy breaks the clinical path into pieces and reviews each one on its own. The default for many plans is a home sleep apnea test first, and in-lab polysomnography is only authorized when comorbidity documentation shows home testing is not appropriate, which is a second request against a stricter bar. Then the titration study that sets up therapy is authorized as a separate event, a third cycle, often not started until the diagnostic result posts. Handled reactively, each step is its own request-deny-appeal loop, and a two-week workup stretches into months. The fix has four moves: screen the order against the plan’s in-lab criteria before anything is submitted, attach the comorbidity evidence when in-lab is clinically required so it is not defaulted to home, file the titration auth the day the diagnostic result posts, and track all three steps as one managed sequence with a single owner. We run those moves inside the systems you already use, so one workup stops living as three restarts. The table of contents maps the whole method; the moves after it are the detail.

How to Run a Sleep Apnea Workup as One Authorization Sequence

The goal is a single managed path from diagnosis to titration that clears without the patient restarting the loop at every step, and without a coordinator chasing three approvals in the dark. Here is what does that, move by move.

1. Screen the Order Against the Plan’s In-Lab Criteria First

Before anything is submitted, check the order against what the plan actually requires for in-lab testing. Many payers default to a home sleep apnea test and only allow in-lab polysomnography when specific criteria are met, comorbidities like heart failure, prior inconclusive home testing, or clinical factors the home study cannot capture. Knowing that bar up front is the whole difference between requesting the right test once and getting defaulted to home, failing, and starting over.

2. Attach Comorbidity Evidence When In-Lab Is Clinically Required

If the patient clinically needs in-lab, the request has to prove it in the payer’s language before the reviewer reaches for the home-test default. That means documenting the qualifying comorbidity, the reason a home study is inadequate here, and the guideline the order follows, all mapped to the plan’s own in-lab criteria. When the request already answers why home testing does not fit this patient, the reviewer has nothing to bounce it to, and the in-lab study is authorized the first time instead of after an appeal.

3. File the Titration Auth the Day the Diagnostic Result Posts

The titration study is a separate authorization, and the time to file it is the moment the diagnostic result posts, not weeks later when someone remembers. Waiting for the result, then starting a fresh request, then waiting on that review is what turns a two-step path into a two-month one. Filing the titration auth the same day the diagnosis lands, with the result attached, collapses the dead time between steps so therapy is not sitting behind an approval nobody started.

4. Track All Three Steps as One Sequence With a Single Owner

The workup only stays fast if one person is watching all three approvals as a connected path, not three separate tickets. Track the home test, the in-lab study, and the titration in one place, with each step’s deadline and the handoff between them visible, so nothing waits for someone to notice it is due. A single owner on the whole sequence is what keeps step two from stalling because step one closed and nobody moved.

5. Hand Sleep Auth to a Dedicated Team

Labs that stop losing patients to the multi-step loop do it by handing sleep authorization to a dedicated team: remote specialists who screen against the in-lab criteria, document the comorbidity case, file the titration the day the result posts, and run all three steps as one sequence, live in 1 to 2 weeks. The pulmonologists go back to reading studies and seeing patients, a trained backup covers every gap, and the three-cycle workup stops being the thing nobody owns end to end. Below is what it sounds like when nobody owns it yet, in providers’ own words.

Key Pain Points and Discussions by Providers

real reports from practice staff, lightly edited

“It is one workup on paper and three authorizations in real life. Home test, then in-lab, then titration, and each one is its own submission and its own wait. The patient thinks they are getting one study; we are fighting three approvals to get them there.” – sleep lab manager

“We had a heart-failure patient denied for in-lab and defaulted to a home test, which was never going to be adequate for him. He did the home study, it did not answer the question, and then we started the in-lab request over. Weeks gone for a step we knew would not work.” – pulmonology practice administrator

“The titration is a separate auth, and half the delay is that nobody files it until the diagnostic result is sitting there for days. By the time the request goes in and gets reviewed, the patient has been waiting a month past their diagnosis for the therapy setup.” – prior authorization coordinator, sleep medicine

“Each step gets treated like a brand-new request. The reviewer does not seem to see it as one continuous workup, so we re-justify the same patient three times, and any one of those cycles can bounce and reset the whole thing.” – billing lead, sleep lab

“Nobody owns the whole path. One person handles the diagnostic auth, the result comes back, and the titration just sits until someone notices. There is no single view of all three steps, so patients fall into the gap between them.” – office manager, pulmonology group

Our Answer

Here is what we actually do. A dedicated remote specialist screens every sleep order against the plan’s in-lab criteria before submission, so the request goes out as the right test the first time instead of getting defaulted to home. When in-lab is clinically required, they document the qualifying comorbidity and the reason a home study is inadequate, mapped to the plan’s own criteria, so the reviewer approves it rather than bouncing it. They file the titration authorization the day the diagnostic result posts, with the result attached, and they track the home test, in-lab study, and titration as one connected sequence with a single owner. Our specialists are credentialed professionals, overseas-trained physicians and US-licensed nurses and pharmacists, working inside your EHR and payer portals, with AI drafting the first pass and a human verifying every submission. This is our sleep study prior authorization support paired with an AI-first workflow, in one paragraph.

Why This Keeps Happening

If it is one clinical workup, why does the payer need three authorizations? Because payer policy breaks the diagnostic path into separately reviewed events. Many plans default to a home sleep apnea test and only authorize in-lab polysomnography when comorbidity documentation shows the home study is not appropriate, which the American Academy of Sleep Medicine addresses in its guidance on when in-lab testing is indicated. Then the titration study that sets up therapy is authorized on its own. Each piece is reviewed as if it stood alone, so what your physician sees as one continuous workup, the payer sees as three requests, each with its own bar to clear.

The volume is the second half of the problem. The American Medical Association’s 2024 prior authorization physician survey reports that practices complete an average of about 39 authorizations per physician every week and spend roughly 13 hours a week processing them, and that 93 percent of physicians say prior authorization delays access to necessary care. A sleep workup that needs three approvals is three times the touchpoints in that already-crowded queue, and when each step is handled reactively, the workup does not get a dedicated owner watching the whole path. It competes with everything else, and the handoffs between steps are exactly where patients get stuck. Closing that gap is what an AI prior authorization workflow with human oversight is built to do.

And the cost is not just a slow worklist. The same AMA survey reports that more than one in four physicians say prior authorization has led to a serious adverse event for a patient in their care, and untreated sleep apnea is a condition where delay carries real risk, especially in patients with cardiac comorbidity. A two-week workup that stretches to ten because the loop restarted at every step is a patient breathing badly at night for two extra months, a lab bed you scheduled around a moving target, and a claim that ages the whole time. The lost weeks are a revenue problem and a patient-safety problem at once.

⚠️ The quiet one that hurts most: The quiet one that hurts most: the gap between steps, where nobody owns the handoff. The diagnostic auth clears, the study runs, the result posts, and then the titration request just sits because the person who handled step one is on to the next patient and step three has no owner yet. It does not look like a denial. It looks like a patient who was diagnosed and is somehow still not scheduled for therapy weeks later. Unless one owner is tracking all three approvals as a single sequence, the workup does not fail loudly; it stalls quietly in the space between authorizations.

Most groups have already tried the obvious fixes before they talk to anyone. Each one fails the same way: the work lands back on the practice. The pattern, in one table:

What you tried What actually happened Who ended up doing the work
Submitted the in-lab request without the comorbidity case Defaulted to a home test that could not answer the question, then restarted the in-lab request from scratch Whoever built the request that day
Waited for the diagnostic result before touching the titration auth Days of dead time, then a fresh request and a fresh review, pushing therapy weeks past diagnosis A coordinator, when they got to it
Handled each step as its own separate ticket Patients fell into the gap between approvals because no one owned the whole path Three different people, none end to end
Gave sleep auth to a dedicated remote specialist In-lab screened against criteria up front, comorbidity documented, titration filed the day the result posts, all three steps tracked as one sequence Someone whose whole job it is

The Solution

So what does “someone whose whole job it is” look like on a sleep workup? The specialist starts where the lab usually cannot: screening the order against the plan’s in-lab criteria before anything is submitted, so the request goes out as the right test rather than getting defaulted to home and failing. When in-lab is clinically required, they build the comorbidity case in the payer’s language up front, so it is approved the first time. Most of the multi-cycle delay is a documentation-and-sequencing problem, and that is exactly what dedicated sleep study prior authorization support is built to solve before it ever becomes an appeal.

Then comes the part a reactive queue cannot do. The specialist files the titration authorization the day the diagnostic result posts, with the result attached, and tracks the home test, in-lab study, and titration as one connected sequence with every deadline and handoff visible. Nothing waits for someone to notice it is due, and step three does not stall because step one closed. For payers that route sleep testing through pulmonary review, the same coverage extends into pulmonology prior authorization support, so the whole respiratory workup is owned end to end.

Behind all of it, AI drafts the first pass and a credentialed human verifies. The workflow reads the plan’s criteria, assembles the matched packet for each step, and flags the deadline and the handoff to the next; a person confirms the clinical case is right and owns the sequence. Every security control that protects the chart data moving through that process is documented and auditable, and the whole approach is described on our HIPAA and security page, because moving clinical documentation through an auth workflow is only safe when the controls are real.

Who Actually Does This Work

Fair question: why would an outsourced team run your sleep authorizations better than your own staff? Because screening orders against in-lab criteria and sequencing a three-step workup is their entire day, not the thing they squeeze between patient check-ins. The people working your auths are credentialed medical professionals: overseas-trained physicians, US-licensed nurses and pharmacists, and PharmDs, all trained in US prior authorization and sleep-medicine workflows. They know when a plan will default to a home test, what comorbidity documentation justifies in-lab, and how to file the titration so therapy is not sitting behind a request nobody started. That is not a generalist task handed to whoever is free; it is a specialty.

We are not a call center. We are a clinical operations partner, a healthcare BPO built on dedicated virtual staff: 500+ credentialed professionals, 24/7 coverage, and the AI-first-pass plus human-verify workflow you just read about behind every one of them. A typical practice is live in 1 to 2 weeks, at up to 70% below the cost of hiring locally, and no one on our side goes out without a trained backup already inside your workflow, so a sleep workup never stalls because the one person who handles auth is on vacation.

And the security piece your compliance officer will ask about: we are audited to SOC 2 Type II with zero exceptions and certified for ISO/IEC 27001:2022, HIPAA, and GDPR, with zero breaches in eight years. Every workstation runs inside a secure enclave on US-based servers, with screen captures and downloads blocked by policy, so PHI never sits on someone’s home laptop. Every client account carries a $5M E&O and cyber liability policy and a BAA signed before any work starts; the full detail lives in our HIPAA and security posture.

Put the routine and the people together, and a specific list of things simply stops happening.

✓ What stops happening: What stops happening: the in-lab request defaulted to a home test that was never going to answer the question. The titration auth that sits for days because nobody filed it when the result posted. The three separate tickets with no single owner, so patients fall into the gap between steps. The two-week workup that stretches to ten because the loop restarted at every stage. The lab bed scheduled around a moving target and the patient breathing badly for two extra months.
2-Week Free Trial

Ready to Run Your Sleep Workups as One Sequence?

How We Permanently Fix the Process

A person alone is not the fix, and neither is a bot alone. The fix is a documented sleep-auth workflow: which payers default to home testing, the exact comorbidity criteria each one requires for in-lab, the rule that titration is a separate authorization, and the handoff between every step, all written down and worked the same way every time. Before we take a single auth for a new practice, we chart where your sleep workups actually stall, defaulted in-lab requests, dead time before titration, gaps between steps, and we build the workflow against that, not against a generic template.

From there the workflow becomes a living playbook rather than tribal knowledge in one coordinator’s head. It records how each payer wants in-lab justified, when the titration auth should be filed, and the exact path from diagnostic result to therapy setup, tracked as one connected sequence. It is written down, kept current as payers change their sleep policies, and owned by the team. When your specialist is out, a trained backup works the same playbook the same way, so a workup never falls into the gap between steps because one person was away.

That is the difference between fighting this month’s three-cycle workups and fixing the process for good, and it is what a dedicated prior authorization partner actually buys you. A coordinator leaving used to mean the sequence lived in someone’s head and patients stalled between approvals again. Under this model the workflow keeps running, the playbook stays, the backup steps in, and a multi-step sleep workup stops being the thing that quietly leaves patients untreated.

The Whole Thing in Four Sentences

One sleep apnea workup needs two or three separate authorizations because payer policy breaks the clinical path into separately reviewed events: a home test by default, in-lab only when comorbidity documentation justifies it, and titration as its own request, so each step restarts the request-deny-appeal loop. Submitting in-lab without the comorbidity case, waiting to file the titration, and handling each step as an isolated ticket all fail the same way. The fix is to screen against the in-lab criteria up front, document the comorbidity when in-lab is required, file the titration the day the result posts, and run all three steps as one owned sequence. A sleep and pulmonology group runs exactly this model with us today, names withheld, no patient data shown.

If you want to check us out before talking to anyone: our security posture is independently auditable, we are an MGMA 2026 Corporate Member, and 800+ providers run back office work with us.

Ready to run your sleep workups as one sequence? Try us risk free: two weeks, your real sleep auth queue, dedicated specialists screening the criteria and sequencing every step, and if it does not earn the handoff, you walk away. From here down is the sales part, and it is short: here is exactly what it costs.

Transparent Weekly Pricing

One Flat Weekly Rate. 45 Hours of Coverage.

No hourly meters, no setup fees, no long-term contracts. Your dedicated team member covers your desk 45 hours every week, and a trained backup steps in at no charge whenever they are out.

Single
$399/ week

One dedicated remote specialist owning your sleep study and titration authorizations end to end, single-site sleep lab or pulmonology practice

Enterprise
$299/ week

10+ remote specialists, multi-location sleep-medicine network, MSO, or PE-backed platform running sleep auth across many ordering providers

  How Pricing Works

45 hours of coverage for less than others charge for 40.

Standard US full-time year: 40 hrs x 52 weeks = 2,080 hours, the federal basis for computing hourly pay per the U.S. Office of Personnel Management. A Staffingly plan: 45 hrs x 52 weeks = 2,340 hours a year, that is 260 additional hours included in your flat rate. $399/week x 52 = $20,748 a year / 2,340 hours = $8.87 per hour. Typical US market rates for healthcare virtual assistants run $9.50 to $13.00 per hour for 40 hours of coverage.

Trained backup VA Dedicated success manager Monthly training updates HIPAA-certified staff $5M E&O and cyber liability

End the Three-Cycle Sleep Workup This Month

You have seen the whole method. The pilot proves it on your own sleep auth queue, with a tracker your team can watch every day.

Start My 2-Week Free Trial

Request Information

Single specialty or multi-site? One payer or many? Tell us your situation and we will map the right coverage within 24 hours.

Frequently Asked Questions

Because payer policy breaks the clinical path into separately reviewed events. Many plans default to a home sleep apnea test and authorize in-lab polysomnography only when comorbidity documentation shows the home study is inadequate, which is a second request against a stricter bar. Then the titration study that sets up therapy is authorized on its own, a third cycle. Each piece is reviewed as if it stood alone, so one continuous workup becomes three approvals, each with its own bar to clear.
Screen the order against the plan’s in-lab criteria before submitting, then document the qualifying comorbidity and the reason a home study is inadequate for this patient, mapped to the payer’s own criteria and the relevant sleep-medicine guideline. When the request already proves why home testing does not fit, the reviewer has nothing to default it to, and the in-lab study is authorized the first time rather than after a failed home study and an appeal.
The day the diagnostic result posts, with the result attached, not weeks later when someone remembers. The titration is a separate authorization, and most of the dead time between diagnosis and therapy comes from waiting to start that request. Filing it the same day the diagnosis lands collapses the gap so the therapy setup is not sitting behind an approval nobody began, which is how a two-step path avoids turning into a two-month one.
Because the payer reviews each authorization as if it stood alone, rather than as one continuous workup. The reviewer for the titration is not looking at the diagnostic approval as context; it is a fresh submission with its own bar. That is why the same patient gets re-justified at each step and why any one cycle can bounce and reset progress. Tracking all three approvals as one owned sequence is what keeps the steps connected on your side even when the payer treats them separately.
Staffingly charges a flat weekly rate per dedicated remote specialist, with lower per-person rates for teams of 5 or more and 10 or more. Every plan covers 45 hours of coverage per week with a trained backup included, and there is no percentage of your reimbursement. The pricing section on this page shows how the flat rate compares with typical US market rates for this work.
No. AI drafts the first pass, screening the order against criteria, assembling the matched packet for each step, and flagging the deadline and the handoff to the next, and a credentialed human verifies every submission and owns the sequence. The clinical judgment stays with people. Automation removes the repetitive assembly and tracking work so the specialist spends their time on the cases that need a human, not on retyping the same documentation three times.
No. Our specialists work inside the sleep-lab EHR and payer portals you already use, so there is no migration and no new platform for your staff to learn. They read your orders and results where they already live and submit through the portals you already have, which is why a typical practice is live in 1 to 2 weeks rather than months.
Usually within the first two weeks. Once a dedicated specialist is screening in-lab requests against the criteria, documenting the comorbidity case up front, and filing the titration the day the result posts, the requests that used to default and restart start clearing the first time, and the dead time between diagnosis and therapy shrinks because one owner is watching the whole sequence.
Your dedicated specialist works a 9-hour day, Monday to Friday, which is 45 hours of coverage each week. The ninth hour is part of the flat weekly rate, not billed as overtime. Over a year that is 2,340 hours of coverage, against the standard US full-time work year of 2,080 hours (40 hours x 52 weeks, the same basis the U.S. Office of Personnel Management uses to compute hourly rates of pay). That is how $399 per week works out to $8.87 per hour.
Dan Nandan, CEO of Staffingly, Inc.

Written By

Dan Nandan
Founder and CEO, Staffingly, Inc. · Piscataway, NJ

Dan Nandan has spent 25+ years in IT consulting and healthcare BPO, was among the first in the US to build an RPO/BPO delivery network in India, and has been featured in Computerworld. He runs the operations and the dedicated virtual teams behind the workflows on this page; the team-voice answers above come from the remote specialists who work them every day.

Connect on LinkedIn

Where the Claims on This Page Come From

Sources & References

  • American Medical Association Prior Authorization Physician Survey. Physician-reported data on prior authorization volume, time burden, and care delays, including that practices complete about 39 authorizations per physician per week and that a large majority report prior authorization delays necessary care. ama-assn.org
  • American Academy of Sleep Medicine Clinical Guidance. Guidance on when in-lab polysomnography is indicated versus home sleep apnea testing, and on the diagnostic and management path for obstructive sleep apnea. aasm.org
  • MGMA Practice Operations and Prior Authorization Resources. Benchmarks and guidance on authorization workload and patient access for medical group practices. mgma.com
  • HFMA Revenue Cycle and Denials Management Resources. Guidance on authorization-related denials, multi-step approval workflows, and the revenue impact of delayed authorizations. hfma.org
  • CAQH Index Report on Prior Authorization. Industry data on the cost, time, and manual burden of prior authorization transactions across payers. caqh.org